Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:3.4.16.2 (
PCP
)
3,761
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Self-injection of phencyclidine HCI (
PCP
) and four of its analogues was examined in baboons. IV injections of drug were dependent upon completion of 160 lever presses (a 160-response fixed-ratio schedule).
A 3
-h time-out period followed each injection, permitting a maximum of eight injections per day. Self-injection performance was first established with cocaine and, once stable, test doses of each drug were substituted for 15 days. All five compounds maintained maximal self-injection performance, differing only in their relative potencies. The order of potency was approximately
PCP
greater than NMPCA = TCPY greater than NNBPCA greater than ketamine. Analysis of the distribution of injections throughout the day indicate that lower doses (and vehicle) were injected mainly during the daylight hours (i.e., 9 AM-6 PM), but as the dose was increased the injections became more uniformly distributed. Only the highest doses of these compounds affected food intake, though the degree of suppression was modest. No differences between these compounds with respect to their abuse potential could be found.
...
PMID:Phencyclidine-analogue self-injection by the baboon. 643 60
The acute effects of a low dose of phencyclidine (
PCP
) and the delayed effects of a high dose of
PCP
on latent inhibition (LI) were assessed in a series of experiments using conditioned taste aversion paradigms. Each paradigm involved a preexposure phase in which water-deprived male rats were allowed access to either water (nonpreexposed; NPE) or 5% sucrose (preexposed; PE), followed by a conditioning phase in which animals were allowed access to sucrose and subsequently injected with the negative reinforcer lithium chloride, and a test phase in which animals were allowed access to both sucrose and water. LI was assessed by comparing the %-sucrose consumed in PE and NPE groups on the test day. The effects of low-dose
PCP
(2.5 mg/kg) were assessed by comparing LI in animals treated with vehicle or
PCP
15 min prior to the onset of the preexposure and conditioning phases. A 4-day paradigm involved 2 days of preexposure followed by a day of conditioning and a test day. This paradigm produced comparable levels of LI in vehicle and
PCP
-treated animals. A 5-day extinction paradigm involved 2 days of preexposure followed by 2 days of conditioning and a test day. This paradigm abolished LI in vehicle and
PCP
-treated animals.
A 3
-day paradigm involved 1 day of preexposure followed by a day of conditioning and a test day. One day of preexposure induced a modified LI effect in both in vehicle and
PCP
-treated animals. The delayed effects of high dose
PCP
(8.6 mg/kg) were assessed by comparing LI in animals treated with vehicle or
PCP
20 h prior to the onset of the preexposure and conditioning phases in the 4-day paradigm.
PCP
disrupted latent inhibition in this paradigm. The results are discussed in the context of their relevance to the ability for
PCP
to model schizophrenic symptomatology.
...
PMID:The delayed effects of phencyclidine (PCP) disrupt latent inhibition in a conditioned taste aversion paradigm. 963 40